To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ERCC1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
398 supporting clones for gene ERCC1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BI552085 brain, hippocampus .a 1 to 741 1 to 742       742/742
(100 %)
4 diff
(99.5 %id)
TI_44171711   .a 4 to 741 86 to 824   tiling clone,   739/824
(89 %)
2 diff
(99.8 %id)
DB468563 hippocampus .a 8 to 205 1 to 198       198/214
(92 %)
4 diff
(98.2 %id)
NM_202001.2   .a 8 to 1280 1 to 1273 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1273/1273
(100 %)
0 diff
(100 %id)
BM789972 stomach .a 26 to 666 1 to 641       641/641
(100 %)
1 diff
(99.9 %id)
BG574302 breast, mammary adenocarcinoma, cell line .a 35 to 913 1 to 874       874/877
(99 %)
11 diff
(98.8 %id)
BM010381 amelanotic melanoma, cell line, skin .a 36 to 764 1 to 731       731/732
(99 %)
4 diff
(99.5 %id)
TI_59385197   .a 36 to 764 102 to 832       731/732
(99 %)
4 diff
(99.5 %id)
BM556010 amelanotic melanoma, cell line, skin .a 37 to 1080 1 to 1044       1044/1135
(91 %)
41 diff
(96.4 %id)
BM048439 carcinoma, cell line, Prostate .a 38 to 770 1 to 739       739/774
(95 %)
38 diff
(95.1 %id)
BI550630 brain, hippocampus .a 44 to 870 1 to 831       735/1128
(65 %)
27 diff
(97.7 %id)
CD387796 embryonic trophoblasts, made from WA01 stemcells .a 49 to 522 20 to 497       478/778
(61 %)
10 diff
(98.8 %id)
BG339400 leiomyosarcoma cell line, uterus .a 55 to 810 1 to 754       754/986
(76 %)
21 diff
(97.9 %id)
BE736283 adenocarcinoma, Pancreas .a 56 to 725 1 to 656       660/925
(71 %)
18 diff
(98.1 %id)
BU182793 melanotic melanoma, skin .a 59 to 795 12 to 753       742/850
(87 %)
8 diff
(99.1 %id)
BQ927348 carcinoma, cell line, Prostate .a 59 to 792 1 to 741       741/830
(89 %)
10 diff
(98.8 %id)
CN314900 embryonic stem cells, DMSO-treated H9 cellline .a 61 to 593 4 to 536       533/536
(99 %)
1 diff
(99.9 %id)
CA390318 eye, RPE/choroid .a 63 to 619 1 to 557       557/557
(100 %)
0 diff
(100 %id)
BG248227 adenocarcinoma cell line, colon .a 64 to 796 1 to 722       722/957
(75 %)
22 diff
(97.8 %id)
BC052813 Uterus, leiomyosarcoma .a 65 to 1256 1 to 1192 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1192/1192
(100 %)
1 diff
(100.0 %id)
BI480769 Native Retinal Pigment Epithelium sheets, retina .a 65 to 731 12 to 678       667/679
(98 %)
1 diff
(99.9 %id)
CN314905 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 66 to 666 1 to 601       601/601
(100 %)
0 diff
(100 %id)
BG770510 melanotic melanoma, high MDR (cell line), skin .a 66 to 794 1 to 732       732/790
(92 %)
10 diff
(98.8 %id)
BG766281 melanotic melanoma, high MDR (cell line), skin .a 66 to 720 1 to 677       677/856
(79 %)
34 diff
(96.1 %id)
BQ222459 epithelioid carcinoma, Pancreas .a 66 to 940 1 to 887       885/889
(99 %)
17 diff
(98.1 %id)
BU902369 leiomyosarcoma, uterus .a 66 to 937 1 to 878       878/878
(100 %)
15 diff
(98.3 %id)
DN998484 bone marrow .a 66 to 795 28 to 757       730/757
(96 %)
0 diff
(100 %id)
AA376006 lung .a 67 to 339 1 to 274       274/274
(100 %)
2 diff
(99.3 %id)
BF686089 leiomyosarcoma cell line, uterus .a 67 to 807 1 to 732       732/917
(79 %)
22 diff
(97.7 %id)
BU538994 adenocarcinoma, cell line, breast .a 67 to 796 1 to 732       732/1021
(71 %)
15 diff
(98.6 %id)
BG120925 adenocarcinoma, cell line, Liver .a 69 to 786 1 to 704       704/933
(75 %)
17 diff
(98.2 %id)
BU538962 adenocarcinoma, cell line, breast .a 69 to 603 1 to 539       539/1307
(41 %)
23 diff
(98.3 %id)
BU956337 adenocarcinoma, cell line, breast .a 69 to 722 1 to 659       659/849
(77 %)
14 diff
(98.4 %id)
BU957764 adenocarcinoma, cell line, breast .a 69 to 724 1 to 659       659/1010
(65 %)
13 diff
(98.8 %id)
BG674551 skin .a 72 to 720 26 to 697       670/882
(75 %)
28 diff
(96.9 %id)
BG831575 epithelioid carcinoma cell line, Pancreas .a 74 to 1031 1 to 961       962/961
(100 %)
26 diff
(97.3 %id)
BM763799 myeloma .a 80 to 594 1 to 515       515/515
(100 %)
1 diff
(99.9 %id)
BM785223 myeloma .a 80 to 679 1 to 600       600/600
(100 %)
1 diff
(99.9 %id)
BM845336 myeloma .a 80 to 388 1 to 309       309/309
(100 %)
0 diff
(100 %id)
CN314902 embryonic stem cells, cell lines H1, H7, andH9 .a 81 to 809 1 to 729       729/729
(100 %)
1 diff
(99.9 %id)
BM912366 amelanotic melanoma, cell line, skin .a 92 to 619 1 to 531       531/1253
(42 %)
11 diff
(99.2 %id)
BE885499 leiomyosarcoma, uterus .a 97 to 791 1 to 689       689/851
(80 %)
21 diff
(97.6 %id)
TI_1948215429   .a 196 to 751 129 to 684   fully sequenced,   556/684
(81 %)
1 diff
(99.9 %id)
TI_1948215593   .a 196 to 1179 126 to 1111 K5R D6T E8R V10C Q12S ... fully sequenced,   986/1111
(88 %)
36 diff
(96.8 %id)
TI_1948215758   .a 196 to 1183 125 to 1109 T256P G258W S259I L260S E261G ... fully sequenced,   983/1107
(88 %)
41 diff
(96.3 %id)
TI_1948215912   .a 196 to 828 129 to 761   fully sequenced,   633/761
(83 %)
1 diff
(99.9 %id)
BM695606 eye, optic nerve .a 275 to 828 1 to 553   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 553/553
(100 %)
3 diff
(99.5 %id)
BG254926 adenocarcinoma, cell line, Prostate .a 315 to 1118 1 to 801       801/1053
(76 %)
19 diff
(98.2 %id)
AV722587 hypothalamus .a 392 to 1073 1 to 679   tiling clone,   679/697
(97 %)
5 diff
(99.3 %id)
CN314898 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 548 to 1150 1 to 603       603/603
(100 %)
4 diff
(99.4 %id)
BU627436 Bone, Enchondroma cell line .a 588 to 1280 711 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 693/693
(100 %)
0 diff
(100 %id)
CA307171 Alveolar Macrophage, lung .a 629 to 1279 669 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 651/651
(100 %)
1 diff
(99.9 %id)
AI436414 B-cell, chronic lymphotic leukemia .a 635 to 1278 644 to 7       638/648
(98 %)
10 diff
(98.5 %id)
TI_1948215430   .a 690 to 1177 602 to 117   fully sequenced,   486/602
(80 %)
0 diff
(100 %id)
TI_1948215594   .a 690 to 1177 602 to 117   fully sequenced,   486/602
(80 %)
0 diff
(100 %id)
TI_1948215759   .a 690 to 1177 599 to 114   fully sequenced,   486/599
(81 %)
0 diff
(100 %id)
CA424323 cell lines, Chondrosarcoma .a 701 to 1279 597 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 579/579
(100 %)
0 diff
(100 %id)
AI807807 pooled .a 721 to 1252 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
TI_1948215913   .a 767 to 1177 524 to 116   fully sequenced,   409/524
(78 %)
1 diff
(99.9 %id)
BM666497 eye, optic nerve .a 767 to 1279 531 to 19   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 513/513
(100 %)
0 diff
(100 %id)
AI803275 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .a 768 to 1279 518 to 8       511/518
(98 %)
3 diff
(99.5 %id)
AA640083 lung, lung tumor .a 796 to 1277 481 to 1       481/490
(98 %)
19 diff
(96.2 %id)
AA489279   .a 816 to 1277 468 to 10     Submitted on the opposite strand 459/468
(98 %)
1 diff
(99.8 %id)
BF828089 head_normal .a 873 to 1084 212 to 1     Submitted on the opposite strand 212/212
(100 %)
2 diff
(99.1 %id)
BG999255 head_normal .a 873 to 1202 1 to 331       331/331
(100 %)
8 diff
(97.6 %id)
AA877247 colon, colon tumor RER+ .a 924 to 1279 354 to 1       354/354
(100 %)
9 diff
(97.5 %id)
AI401182 B-cell, chronic lymphotic leukemia .a 943 to 1279 352 to 16   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 337/337
(100 %)
3 diff
(99.2 %id)
CB216922 normal endometrium, mid-secretory phase,cycle day 23, uterus .a 987 to 1280 1 to 294   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 294/294
(100 %)
0 diff
(100 %id)
BF847580 lung_normal .a 1015 to 1196 183 to 3     Submitted on the opposite strand 181/199
(90 %)
0 diff
(100 %id)
BF802354 colon_ins .a 1029 to 1151 1 to 122       122/127
(96 %)
8 diff
(93.8 %id)
AA410857 ovarian tumor, ovary .b 1 to 466 1 to 460   tiling clone,   462/460
(100 %)
8 diff
(98.3 %id)
AA235629 ovarian tumor, ovary .b 693 to 1013 321 to 1   tiling clone,   321/321
(100 %)
23 diff
(92.9 %id)
CB992580 placenta, pre-eclamptic placenta .c 1 to 647 28 to 681   tiling clone,   654/842
(77 %)
9 diff
(99.0 %id)
BX097972 liver and spleen .c 309 to 1113 1 to 807   tiling clone,   807/812
(99 %)
5 diff
(99.4 %id)
CR736697 liver and spleen .c 309 to 1089 1 to 783       783/783
(100 %)
4 diff
(99.5 %id)
T95367 liver and spleen .c 310 to 570 1 to 259       259/450
(57 %)
6 diff
(98.7 %id)
AA761510 germinal center B cell .c 776 to 1261 503 to 28   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 476/482
(98 %)
15 diff
(96.9 %id)
T95289 liver and spleen .c 796 to 1228 429 to 1       429/430
(99 %)
9 diff
(98.0 %id)
AI798974 pooled .c 814 to 1261 464 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 448/448
(100 %)
8 diff
(98.3 %id)
BQ671113 epidermoid carcinoma, cell line, salivary gland .d 1 to 906 1 to 912   tiling clone,   910/924
(98 %)
11 diff
(98.9 %id)
NM_001983.3   .d 1 to 3382 1 to 3382 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 3382/3382
(100 %)
0 diff
(100 %id)
AF001925   .d 5 to 1101 1 to 1097 exact     1097/1097
(100 %)
1 diff
(100.0 %id)
AH002675   .d 5 to 1101 1 to 1097 exact     1097/1097
(100 %)
1 diff
(100.0 %id)
M13194   .d 5 to 1101 1 to 1097 exact     1097/1097
(100 %)
1 diff
(100.0 %id)
M28650   .d 5 to 1101 1 to 1097 exact     1097/1098
(99 %)
2 diff
(99.9 %id)
BQ231211 melanotic melanoma, skin .d 7 to 862 1 to 858       858/858
(100 %)
4 diff
(99.6 %id)
CR590512 T cells (Jurkat cell line) Cot10-normalized .d 39 to 1070 1 to 1032 exact     1032/1032
(100 %)
0 diff
(100 %id)
AL558124 T cells from T cell leukemia .d 39 to 702 1 to 664   fully sequenced,   664/664
(100 %)
0 diff
(100 %id)
BU781579 insulinoma, Pancreas .d 60 to 620 1 to 561   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 561/561
(100 %)
6 diff
(99.0 %id)
AI929005 brain, frontal lobe .d 65 to 535 1 to 471   fully sequenced,   471/471
(100 %)
1 diff
(99.8 %id)
AK314884 cerebellum .d 69 to 1040 1 to 972 A53P     972/972
(100 %)
3 diff
(99.7 %id)
AW163286 brain, frontal lobe .d 79 to 602 1 to 524   fully sequenced,   524/524
(100 %)
0 diff
(100 %id)
BC008930 Lung, small cell carcinoma .d 85 to 1109 1 to 1025 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 1025/1025
(100 %)
1 diff
(100.0 %id)
AA035765 uterus .d 89 to 437 1 to 347     Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 347/378
(91 %)
16 diff
(95.8 %id)
BT019806   .d 147 to 1038 1 to 892       892/894
(99 %)
2 diff
(99.8 %id)
TI_149293179   .d 252 to 1104 934 to 88   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 847/993
(85 %)
12 diff
(98.8 %id)
TI_149316000   .d 252 to 1092 927 to 93   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 835/984
(84 %)
10 diff
(99.0 %id)
TI_159693797   .d 252 to 1101 975 to 138   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 838/971
(86 %)
36 diff
(96.3 %id)
BU789909 insulinoma, Pancreas .d 270 to 692 8 to 430   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 423/430
(98 %)
1 diff
(99.8 %id)
TI_154127018   .d 297 to 1092 884 to 100   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 785/939
(83 %)
17 diff
(98.2 %id)
BF037383 adenocarcinoma, ovary .d 322 to 1045 1 to 717       721/733
(98 %)
19 diff
(97.5 %id)
CA309533 Alveolar Macrophage, lung .d 353 to 1094 760 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 742/742
(100 %)
0 diff
(100 %id)
BQ574605 Chondrosarcoma Grade II, Left Pelvis .d 362 to 1095 752 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 734/734
(100 %)
1 diff
(99.9 %id)
BM988517 lung, Metastatic Chondrosarcoma .d 370 to 1092 739 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 723/724
(99 %)
2 diff
(99.8 %id)
BU625161 cell lines, Enchondroma .d 375 to 1093 738 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 720/720
(100 %)
3 diff
(99.6 %id)
CB321835 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 378 to 1092 731 to 17   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 715/715
(100 %)
2 diff
(99.8 %id)
CR616265 Placenta Cot 25-normalized .d 393 to 1101 1 to 709   tiling clone,   709/709
(100 %)
0 diff
(100 %id)
AL545728 placenta, Placenta Cot 25-normalized .d 393 to 1101 1 to 708   fully sequenced,   708/708
(100 %)
2 diff
(99.8 %id)
BQ006350 Chondrosarcoma, Left Pelvis .d 399 to 1095 717 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 699/699
(100 %)
3 diff
(99.6 %id)
TI_149286156   .d 399 to 1094 781 to 85   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 697/697
(100 %)
5 diff
(99.3 %id)
CA308883 Alveolar Macrophage, lung .d 403 to 1099 714 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 696/696
(100 %)
1 diff
(99.9 %id)
BU682517 lung .d 409 to 1104 715 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 697/697
(100 %)
1 diff
(99.9 %id)
BU625078 cell lines, Enchondroma .d 424 to 1099 694 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 676/676
(100 %)
1 diff
(99.9 %id)
BM450988 eye, retinoblastoma .d 426 to 1094 1 to 669       669/702
(95 %)
1 diff
(99.9 %id)
CD370198 Alveolar Macrophage, lung .d 429 to 1099 689 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 671/671
(100 %)
0 diff
(100 %id)
BF792935 adrenal cortex carcinoma, cell line, adrenal gland .d 445 to 1100 1 to 657       657/675
(97 %)
13 diff
(98.1 %id)
AI928779 brain, frontal lobe .d 505 to 1098 602 to 8   fully sequenced,   595/602
(98 %)
1 diff
(99.9 %id)
AW157276 brain, frontal lobe .d 541 to 1098 565 to 8   fully sequenced,   558/565
(98 %)
1 diff
(99.9 %id)
BU786723 insulinoma, Pancreas .d 590 to 1092 520 to 18   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 503/503
(100 %)
0 diff
(100 %id)
AL580029 T cells from T cell leukemia .d 641 to 1070 428 to 1   fully sequenced,   428/428
(100 %)
7 diff
(98.4 %id)
BU789636 insulinoma, Pancreas .d 641 to 1095 477 to 23   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 455/455
(100 %)
0 diff
(100 %id)
AL545696 placenta, Placenta Cot 25-normalized .d 718 to 1066 346 to 1   fully sequenced,   346/346
(100 %)
4 diff
(98.9 %id)
AA035596 uterus .d 841 to 1093 286 to 32   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 255/281
(90 %)
12 diff
(95.8 %id)
CF130889 Chondrosarcoma Lung Metastasis cell lines, lung .e 1 to 614 1 to 615   tiling clone,   615/615
(100 %)
1 diff
(99.9 %id)
TI_154193322   .e 1 to 913 51 to 959 L191P A192G A199R S201X A214G ... tiling clone,   909/1037
(87 %)
25 diff
(97.6 %id)
CV026492 mixed .e 79 to 666 1 to 588       588/588
(100 %)
2 diff
(99.7 %id)
EL734825 mixed .e 79 to 715 1 to 637       637/639
(99 %)
2 diff
(99.7 %id)
CN314897 embryonic stem cells, cell lines H1, H7, andH9 .e 80 to 746 1 to 667       667/667
(100 %)
0 diff
(100 %id)
BP431154   .e 106 to 503 1 to 398       398/400
(99 %)
6 diff
(98.5 %id)
AA968526 Kidney, kidney tumor .e 135 to 501 360 to 1       360/360
(100 %)
36 diff
(90.0 %id)
T27756 colon, endothelial .e 153 to 452 10 to 311       302/311
(97 %)
3 diff
(99.1 %id)
BG900847 cartilage .e 208 to 705 80 to 577       498/515
(96 %)
1 diff
(99.9 %id)
CB163829 Liver .e 240 to 814 43 to 617       575/607
(94 %)
0 diff
(100 %id)
CN482258 eye .e 266 to 878 1 to 613   tiling clone,   613/613
(100 %)
0 diff
(100 %id)
N78383 multiple sclerosis lesions .e 267 to 755 1 to 491       491/491
(100 %)
18 diff
(96.4 %id)
R72675 breast .e 305 to 706 1 to 403       405/405
(100 %)
15 diff
(96.3 %id)
D53320   .e 321 to 576 1 to 254       254/254
(100 %)
2 diff
(99.3 %id)
D54089   .e 321 to 503 1 to 182       182/206
(88 %)
1 diff
(99.6 %id)
D54451   .e 321 to 659 1 to 336       336/336
(100 %)
4 diff
(98.9 %id)
D55175   .e 321 to 628 1 to 308       308/308
(100 %)
3 diff
(99.1 %id)
D54091   .e 322 to 655 1 to 332       332/332
(100 %)
4 diff
(98.8 %id)
BQ957119 large cell carcinoma, lung .f 1 to 919 1 to 930       930/940
(98 %)
41 diff
(95.7 %id)
BI256238 cervical carcinoma cell line, cervix .f 2 to 491 1 to 490   tiling clone,   490/490
(100 %)
0 diff
(100 %id)
BQ675265 epidermoid carcinoma, cell line, salivary gland .f 447 to 1190 1 to 751       751/921
(81 %)
16 diff
(98.3 %id)
NM_001166049.1   .f 447 to 3756 1 to 3310 exact RefSeq, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 3310/3310
(100 %)
0 diff
(100 %id)
TI_57191768   .f 455 to 1295 45 to 886       842/843
(99 %)
19 diff
(97.8 %id)
CN314901 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .f 461 to 1057 1 to 597   tiling clone,   597/598
(99 %)
6 diff
(99.0 %id)
BY797274 eye .f 465 to 1015 1 to 551       551/551
(100 %)
1 diff
(99.9 %id)
BI908640 leukocyte .f 466 to 1160 1 to 689       689/693
(99 %)
27 diff
(96.2 %id)
BQ638046 eye, retina .f 470 to 1064 1 to 595       595/595
(100 %)
1 diff
(99.9 %id)
TI_57234949   .f 471 to 1160 34 to 717       684/721
(94 %)
15 diff
(98.0 %id)
AF433652 ovarian cancer .f 472 to 711 1 to 240       240/240
(100 %)
0 diff
(100 %id)
CD613662   .f 472 to 1070 599 to 7       593/599
(98 %)
6 diff
(99.0 %id)
BF974540 B-cells, primary B-cells from tonsils (cell line) .f 472 to 1298 1 to 831       831/872
(95 %)
32 diff
(96.4 %id)
BM011513 brain, neuroblastoma, cell line .f 472 to 1239 1 to 766       766/879
(87 %)
19 diff
(97.9 %id)
TI_59380679   .f 473 to 1239 101 to 865       765/878
(87 %)
18 diff
(98.0 %id)
CD613663   .f 474 to 1070 1 to 600       600/608
(98 %)
10 diff
(98.4 %id)
CA487240   .f 474 to 1017 1 to 544       544/903
(60 %)
3 diff
(99.7 %id)
DB464046 hippocampus .f 513 to 986 1 to 474       474/474
(100 %)
0 diff
(100 %id)
DB470790 hippocampus .f 513 to 974 1 to 462       462/462
(100 %)
10 diff
(97.9 %id)
DB476631 hippocampus .f 513 to 1016 1 to 503       503/503
(100 %)
1 diff
(99.9 %id)
DA096786 cerebellum .f 516 to 1020 2 to 506   capped   505/505
(100 %)
1 diff
(99.9 %id)
BG328869 adenocarcinoma cell line, colon .f 520 to 1111 1 to 591       591/591
(100 %)
3 diff
(99.5 %id)
AB069681   .f 527 to 1475 1 to 949 exact tiling clone,   949/949
(100 %)
1 diff
(99.9 %id)
BM917656 blood, natural killer cells, cell line .f 527 to 1121 8 to 602       595/1139
(52 %)
6 diff
(99.5 %id)
CK429300 eye, lacrimal gland .f 529 to 1175 1 to 647       647/647
(100 %)
1 diff
(99.9 %id)
CN314904 embryonic stem cells, DMSO-treated H9 cellline .f 530 to 1056 1 to 527       527/527
(100 %)
1 diff
(99.9 %id)
BQ950441 sciatic nerve .f 532 to 1113 99 to 685       587/1095
(53 %)
9 diff
(99.2 %id)
CD613664   .f 533 to 745 213 to 1       213/220
(96 %)
1 diff
(99.6 %id)
CD613665   .f 533 to 747 8 to 222       215/223
(96 %)
2 diff
(99.2 %id)
AA424237   .f 573 to 1117 1 to 541       541/544
(99 %)
12 diff
(97.8 %id)
BG338981 leiomyosarcoma cell line, uterus .f 603 to 1417 1 to 817       817/1015
(80 %)
22 diff
(97.9 %id)
TI_149278369   .f 698 to 1546 934 to 93   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 842/1087
(77 %)
21 diff
(98.1 %id)
BQ010328 Chondrosarcoma, Left Pubic Bone .f 777 to 1468 710 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 692/692
(100 %)
0 diff
(100 %id)
BI197921 brain, neuroblastoma .f 809 to 1478 1 to 672       672/763
(88 %)
10 diff
(98.7 %id)
AI870332 anaplastic oligodendroglioma, brain .f 987 to 1468 487 to 7       481/490
(98 %)
4 diff
(99.2 %id)
AA805460 germinal center B cell .f 1014 to 1364 426 to 82   AAA   345/411
(83 %)
17 diff
(95.9 %id)
AI095301 senescent fibroblast .f 1019 to 1473 478 to 27   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 452/485
(93 %)
13 diff
(97.4 %id)
BU678445 lung .f 1037 to 1546 528 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 510/510
(100 %)
1 diff
(99.9 %id)
BE819277 breast_normal .f 1270 to 1466 207 to 11       197/207
(95 %)
5 diff
(97.6 %id)
DA369025 subthalamic nucleus .f 2061 to 2601 2 to 542   tiling clone, capped   541/541
(100 %)
1 diff
(99.9 %id)
BU599122 mixed (pool of 40 RNAs) .f 2100 to 2792 1 to 698   tiling clone,   698/808
(86 %)
16 diff
(98.1 %id)
AW798079 uterus .f 2367 to 2519 1 to 154       154/163
(94 %)
9 diff
(94.5 %id)
BE939410 uterus .f 2367 to 2519 1 to 154       154/163
(94 %)
9 diff
(94.5 %id)
BF985032 uterus .f 2367 to 2519 1 to 154       154/163
(94 %)
9 diff
(94.5 %id)
F07293 brain, total brain .f 2380 to 2569 1 to 190       190/190
(100 %)
0 diff
(100 %id)
F03559 brain, total brain .f 3465 to 3756 291 to 1   tiling clone,   291/291
(100 %)
1 diff
(99.7 %id)
TI_57162987   .g 1 to 865 33 to 901 Q54H K218E P219T A220R D221R ... tiling clone,   869/901
(96 %)
15 diff
(98.4 %id)
BI838348 pooled pancreas and spleen .g 5 to 865 1 to 865 Q54H K218E P219T A220R D221R ... tiling clone,   865/865
(100 %)
15 diff
(98.3 %id)
BI819060 pooled brain, lung, testis .h 1 to 882 1 to 877 P238L H239T L240S P241H S242P ... tiling clone,   877/880
(99 %)
12 diff
(98.7 %id)
TI_57196682   .h 1 to 882 37 to 913 P238L H239T L240S P241H S242P ...     877/916
(95 %)
12 diff
(98.7 %id)
BE383777 brain, neuroblastoma .i 1 to 590 1 to 599   tiling clone,   599/604
(99 %)
16 diff
(97.4 %id)
BI194899 brain, neuroblastoma .i 2 to 930 1 to 936 Q54R A55R A56P P57L Q58R ... tiling clone,   936/970
(96 %)
23 diff
(97.7 %id)
BG696259 skin .i 90 to 798 1 to 718   tiling clone,   717/719
(99 %)
29 diff
(96.0 %id)
CD358018 testis .j 1 to 638 1 to 639   tiling clone,   639/920
(69 %)
15 diff
(98.4 %id)
AI933046 anaplastic oligodendroglioma, brain .j 473 to 817 355 to 11   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 345/345
(100 %)
0 diff
(100 %id)
BF686006 leiomyosarcoma cell line, uterus .k 1 to 804 1 to 782   tiling clone,   782/954
(81 %)
34 diff
(96.5 %id)
BQ721851 sympathetic trunk .k 9 to 844 1 to 843 F164S A165P L166C R167G V168S ... tiling clone,   843/846
(99 %)
14 diff
(98.4 %id)
CN314896 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k 25 to 805 1 to 781   tiling clone,   781/781
(100 %)
1 diff
(99.9 %id)
BE790744 lung, small cell carcinoma .l 1 to 739 1 to 742 L187S L188* tiling clone,   742/838
(88 %)
15 diff
(98.3 %id)
DN993613 brain, whole brain .l 30 to 615 9 to 595   tiling clone,   587/595
(98 %)
1 diff
(99.9 %id)
TI_57176837   .m 1 to 983 52 to 1032 C49R E89R P90A G91W E92G ... tiling clone,   981/1032
(95 %)
32 diff
(96.9 %id)
BI829398 brain, medulla .m 8 to 983 1 to 974 C49R E89R P90A G91W E92G ... tiling clone,   974/974
(100 %)
32 diff
(96.8 %id)
AK092039   .n 1 to 3118 2 to 3119 exact tiling clone, available from FLJ,   3119/3119
(100 %)
10 diff
(99.7 %id)
AX747328   .n 1 to 3118 2 to 3119 exact     3119/3119
(100 %)
10 diff
(99.7 %id)
DA651661   .n 1 to 544 2 to 545   capped   544/544
(100 %)
1 diff
(99.9 %id)
TI_154034526   .n 195 to 838 738 to 89   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 650/807
(80 %)
21 diff
(97.4 %id)
BF724730 eye, Iris .n 201 to 712 1 to 512       512/512
(100 %)
2 diff
(99.7 %id)
AW189009 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 203 to 692 490 to 1       490/506
(96 %)
21 diff
(95.9 %id)
CA416869 Chondrosarcoma Cell line .n 222 to 829 625 to 17   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 609/609
(100 %)
2 diff
(99.7 %id)
BQ000887 lung, Metastatic Chondrosarcoma .n 228 to 837 629 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 611/611
(100 %)
2 diff
(99.7 %id)
BF685745 leiomyosarcoma cell line, uterus .n 229 to 727 1 to 509       485/1006
(48 %)
21 diff
(98.0 %id)
CA415582 Chondrosarcoma Grade II, Left Pelvis .n 244 to 827 602 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 584/594
(98 %)
0 diff
(100 %id)
BU680975 lung .n 248 to 831 603 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 585/585
(100 %)
1 diff
(99.9 %id)
AW022536 cochlea, ear .n 256 to 678 12 to 437       426/437
(97 %)
3 diff
(99.4 %id)
AI191577   .n 268 to 828 563 to 3       561/563
(99 %)
9 diff
(98.5 %id)
BM699327 eye, fetal eyes .n 274 to 516 1 to 243   fully sequenced, Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 243/243
(100 %)
0 diff
(100 %id)
BF091700 testis_normal .n 306 to 545 22 to 260       243/260
(93 %)
0 diff
(100 %id)
AI377504   .n 307 to 841 541 to 7   tiling clone,   535/761
(70 %)
9 diff
(98.9 %id)
AA866091 Kidney, kidney tumor .n 311 to 838 533 to 1       533/549
(97 %)
9 diff
(98.4 %id)
BE041815 pooled .n 316 to 830 536 to 24   AAA Submitted on the opposite strand 513/513
(100 %)
8 diff
(98.5 %id)
AV744845 cord Blood .n 317 to 832 32 to 537   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 509/537
(94 %)
9 diff
(98.4 %id)
AA885043 pooled .n 320 to 836 515 to 2       514/624
(82 %)
14 diff
(97.8 %id)
BQ018499 lung, Metastatic Chondrosarcoma .n 331 to 835 523 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 505/513
(98 %)
0 diff
(100 %id)
AI143627 heart .n 348 to 836 492 to 4       489/492
(99 %)
1 diff
(99.8 %id)
AA907548 pooled .n 349 to 827 482 to 6       477/482
(98 %)
6 diff
(98.8 %id)
AI471448 colon, moderately-differentiated adenocarcinoma .n 353 to 691 337 to 1       337/337
(100 %)
17 diff
(95.0 %id)
AI240026 pooled .n 355 to 832 485 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 479/475
(100 %)
19 diff
(96.0 %id)
AW796198 uterus .n 365 to 545 183 to 1       183/183
(100 %)
6 diff
(96.8 %id)
AI335349 2 pooled tumors (clear cell type), Kidney .n 373 to 837 473 to 9       465/473
(98 %)
0 diff
(100 %id)
AA996054 breast .n 379 to 838 461 to 2       460/461
(99 %)
4 diff
(99.2 %id)
AA972775 carcinoid, lung .n 385 to 836 465 to 14   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 452/452
(100 %)
0 diff
(100 %id)
AI369912 anaplastic oligodendroglioma, brain .n 386 to 836 460 to 10       451/460
(98 %)
0 diff
(100 %id)
AI130716 heart .n 394 to 834 445 to 5       441/445
(99 %)
0 diff
(100 %id)
DB530141 hippocampus .n 401 to 839 1 to 441     Submitted on the opposite strand 441/442
(99 %)
3 diff
(99.4 %id)
DB535899 hippocampus .n 408 to 834 12 to 438     Submitted on the opposite strand 430/440
(97 %)
6 diff
(98.7 %id)
AI086816 senescent fibroblast .n 408 to 829 443 to 22   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 422/430
(98 %)
0 diff
(100 %id)
AI239796 pooled .n 408 to 838 442 to 11   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 432/488
(88 %)
28 diff
(94.3 %id)
AW592093 pooled .n 409 to 830 430 to 7       424/430
(98 %)
4 diff
(99.1 %id)
AI185419 lung .n 410 to 835 422 to 1       422/473
(89 %)
11 diff
(97.7 %id)
BG999299 head_normal .n 415 to 545 1 to 130       128/130
(98 %)
9 diff
(93.1 %id)
DB539204 hippocampus .n 415 to 839 1 to 424     Submitted on the opposite strand 424/425
(99 %)
2 diff
(99.6 %id)
AW104653 ovary, tumor, 5 pooled (see description) .n 419 to 692 274 to 1       274/274
(100 %)
2 diff
(99.3 %id)
AW469094 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 424 to 692 269 to 1       269/269
(100 %)
0 diff
(100 %id)
AI424656 brain, glioblastoma (pooled) .n 425 to 829 399 to 1       401/417
(96 %)
17 diff
(96.0 %id)
F28460 pectoral muscle (after mastectomy) .n 436 to 792 1 to 357       357/357
(100 %)
0 diff
(100 %id)
CA443608 lung, Metastatic Chondrosarcoma .n 441 to 838 416 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 398/398
(100 %)
0 diff
(100 %id)
BM669989 eye, fetal eyes .n 455 to 829 391 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 375/375
(100 %)
0 diff
(100 %id)
AW013980   .n 463 to 831 386 to 18   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 369/369
(100 %)
0 diff
(100 %id)
AI000695   .n 485 to 816 333 to 1       333/408
(81 %)
23 diff
(94.4 %id)
BE819297 breast_normal .n 526 to 822 11 to 307       297/307
(96 %)
2 diff
(99.4 %id)
BE831455 marrow .n 548 to 835 289 to 2       288/289
(99 %)
1 diff
(99.7 %id)
BE772417 prostate_tumor .n 553 to 822 1 to 270       270/270
(100 %)
1 diff
(99.7 %id)
AW796195 uterus .n 561 to 825 268 to 3       266/268
(99 %)
1 diff
(99.7 %id)
BE701287 nervous_normal .n 561 to 823 262 to 1       262/262
(100 %)
5 diff
(98.1 %id)
BE772375 prostate_tumor .n 561 to 686 126 to 1       126/126
(100 %)
0 diff
(100 %id)
BE772379 prostate_tumor .n 561 to 832 1 to 272       272/276
(98 %)
4 diff
(98.6 %id)
BE772396 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
13 diff
(95.1 %id)
BE772406 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772407 prostate_tumor .n 561 to 822 262 to 1       262/262
(100 %)
1 diff
(99.7 %id)
BE772411 prostate_tumor .n 561 to 832 277 to 6       272/277
(98 %)
0 diff
(100 %id)
BE772412 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772413 prostate_tumor .n 561 to 822 262 to 1       262/262
(100 %)
1 diff
(99.7 %id)
BE772414 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
2 diff
(99.3 %id)
BE772415 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
2 diff
(99.3 %id)
BE772416 prostate_tumor .n 561 to 832 1 to 272       272/277
(98 %)
5 diff
(98.2 %id)
BE772418 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772420 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772422 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772423 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772425 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
4 diff
(98.5 %id)
BE772439 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE772456 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE819273 breast_normal .n 561 to 822 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
BE819282 breast_normal .n 561 to 795 235 to 1       235/235
(100 %)
7 diff
(97.1 %id)
BE819295 breast_normal .n 561 to 829 280 to 12       269/280
(96 %)
1 diff
(99.7 %id)
BE831470 marrow .n 561 to 825 274 to 9       266/274
(97 %)
0 diff
(100 %id)
BE831471 marrow .n 561 to 822 1 to 263       263/263
(100 %)
2 diff
(99.3 %id)
BE831479 marrow .n 561 to 829 274 to 6       269/274
(98 %)
0 diff
(100 %id)
BE831492 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831493 marrow .n 561 to 822 273 to 12       262/273
(95 %)
2 diff
(99.3 %id)
BE831495 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831497 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831500 marrow .n 561 to 816 1 to 256       256/256
(100 %)
1 diff
(99.7 %id)
BE831502 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831503 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831505 marrow .n 561 to 835 277 to 2       276/277
(99 %)
2 diff
(99.3 %id)
BE831506 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831508 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831518 marrow .n 561 to 832 1 to 272       272/274
(99 %)
3 diff
(99.0 %id)
BE831520 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831522 marrow .n 561 to 822 262 to 1       262/262
(100 %)
1 diff
(99.7 %id)
BE831528 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BE831530 marrow .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BF373082 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
6 diff
(97.8 %id)
BF373097 prostate_tumor .n 561 to 822 262 to 1       262/262
(100 %)
3 diff
(98.9 %id)
BI051378 placenta_normal .n 561 to 867 327 to 21       307/327
(93 %)
0 diff
(100 %id)
BQ373107 prostate_tumor .n 561 to 822 1 to 262       262/262
(100 %)
0 diff
(100 %id)
BF373075 prostate_tumor .n 582 to 822 22 to 264       244/264
(92 %)
7 diff
(97.4 %id)
BG165193 hypernephroma, cell line, Kidney .n 593 to 837 1 to 245   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 245/245
(100 %)
0 diff
(100 %id)
FN145103 breast carcinoma .n 594 to 677 1 to 81       81/87
(93 %)
4 diff
(95.5 %id)
CB114128 Liver .n 618 to 835 1 to 217   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 217/217
(100 %)
1 diff
(99.6 %id)
BE772403 prostate_tumor .n 629 to 822 1 to 194       194/194
(100 %)
0 diff
(100 %id)
BE772447 prostate_tumor .n 629 to 822 1 to 194       194/194
(100 %)
0 diff
(100 %id)
BE772377 prostate_tumor .n 635 to 832 1 to 198       198/203
(97 %)
6 diff
(97.1 %id)
CN356156 embryonic stem cells, cell lines H1, H7, andH9 .n 640 to 1219 1 to 580       580/580
(100 %)
3 diff
(99.5 %id)
DA761332 tongue .n 641 to 1155 2 to 516   capped   515/515
(100 %)
0 diff
(100 %id)
AA903617 pooled germ cell tumors .n 658 to 833 176 to 1       176/176
(100 %)
5 diff
(97.2 %id)
FN098395 breast carcinoma .n 669 to 771 103 to 1     Submitted on the opposite strand 103/103
(100 %)
2 diff
(98.1 %id)
AA577792 gastric tumor, stomach .n 673 to 829 160 to 4       157/160
(98 %)
0 diff
(100 %id)
BE832630 marrow .n 680 to 822 143 to 1       143/143
(100 %)
0 diff
(100 %id)
BM011724 brain, neuroblastoma, cell line .n 683 to 1553 1 to 860   tiling clone,   860/882
(97 %)
15 diff
(98.3 %id)
TI_59380898   .n 684 to 1553 98 to 956       859/881
(97 %)
14 diff
(98.5 %id)
C00084   .n 691 to 835 1 to 145       145/145
(100 %)
0 diff
(100 %id)
FN107658 breast carcinoma .n 705 to 819 114 to 1     Submitted on the opposite strand 114/114
(100 %)
2 diff
(98.3 %id)
BG056641 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .n 710 to 829 121 to 2       120/121
(99 %)
0 diff
(100 %id)
DB464641 hippocampus .n 843 to 1286 1 to 442       442/442
(100 %)
6 diff
(98.7 %id)
DA951441 Spleen .n 949 to 1516 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
BG390552 embryonal carcinoma, cell line, testis .n 950 to 1028 1 to 79       79/79
(100 %)
0 diff
(100 %id)
DB259516 uterus .n 969 to 1547 2 to 580   capped   579/579
(100 %)
2 diff
(99.7 %id)
BF084661 colon .n 975 to 1468 19 to 508       490/508
(96 %)
0 diff
(100 %id)
CD722605 eye, lacrimal gland .n 1035 to 1653 1 to 619       619/619
(100 %)
0 diff
(100 %id)
BQ673678 epidermoid carcinoma, cell line, salivary gland .n 1086 to 1576 1 to 491       491/973
(50 %)
20 diff
(98.0 %id)
BE769851 prostate_tumor .n 1156 to 1446 1 to 291       291/292
(99 %)
9 diff
(97.0 %id)
BE769847 prostate_tumor .n 1175 to 1477 1 to 301       301/301
(100 %)
0 diff
(100 %id)
DA949227 Spleen .n 1198 to 1768 2 to 572   capped   571/571
(100 %)
1 diff
(99.9 %id)
AI634135 pooled germ cell tumors .n 1218 to 1793 1 to 575     Submitted on the opposite strand 575/575
(100 %)
0 diff
(100 %id)
BE769846 prostate_tumor .n 1229 to 1477 1 to 253       253/253
(100 %)
15 diff
(94.1 %id)
DA427932 colon .n 1296 to 1840 2 to 546   capped   545/545
(100 %)
3 diff
(99.5 %id)
DB195088 trachea .n 1332 to 1835 2 to 505   capped   504/504
(100 %)
0 diff
(100 %id)
CD624204   .n 1338 to 1826 7 to 494       488/498
(97 %)
6 diff
(98.8 %id)
BQ227841 epithelioid carcinoma, Pancreas .n 1339 to 2195 1 to 863   tiling clone,   863/863
(100 %)
9 diff
(99.0 %id)
BE772158 prostate_tumor .n 1350 to 1477 17 to 143       127/143
(88 %)
0 diff
(100 %id)
AA862835 pooled germ cell tumors .n 1363 to 1700 1 to 338     Submitted on the opposite strand 338/338
(100 %)
6 diff
(98.3 %id)
CD624202   .n 1503 to 1707 1 to 204       204/214
(95 %)
7 diff
(96.8 %id)
AA155591 Pancreas .n 1516 to 1775 1 to 260     Submitted on the opposite strand 260/260
(100 %)
0 diff
(100 %id)
AA375540 lung .n 1617 to 1788 1 to 172       172/172
(100 %)
0 diff
(100 %id)
DA617063   .n 1845 to 2372 2 to 529   capped   528/535
(98 %)
1 diff
(99.9 %id)
DA617069   .n 1845 to 2370 2 to 527   capped   526/526
(100 %)
1 diff
(99.9 %id)
AA928611 pooled germ cell tumors .n 1851 to 2288 1 to 436     Submitted on the opposite strand 436/508
(85 %)
19 diff
(96.3 %id)
BF529827 anaplastic oligodendroglioma with 1p/19qloss, brain .n 2008 to 2830 1 to 851   tiling clone,   851/1068
(79 %)
67 diff
(93.8 %id)
BM990882 lung, Lung Focal Fibrosis .n 2383 to 3062 1 to 679     Submitted on the opposite strand 679/679
(100 %)
2 diff
(99.8 %id)
BU632118 cell lines, Chondrosarcoma .n 2424 to 3118 713 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 695/695
(100 %)
2 diff
(99.8 %id)
BG111047 Bone, osteosarcoma, cell line .n 2481 to 3115 1 to 639       639/658
(97 %)
11 diff
(98.4 %id)
BF826048 head_normal .n 2490 to 2932 1 to 441       441/441
(100 %)
6 diff
(98.7 %id)
BX112751 breast .n 2498 to 3118 1 to 621   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 621/621
(100 %)
0 diff
(100 %id)
R48185 breast .n 2498 to 2838 1 to 354   fully sequenced,   354/354
(100 %)
20 diff
(94.4 %id)
H42953 breast .n 2498 to 2899 1 to 410   fully sequenced,   410/410
(100 %)
4 diff
(99.1 %id)
BQ019990 Chondrosarcoma, Left Pubic Bone .n 2507 to 3119 631 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 613/613
(100 %)
2 diff
(99.7 %id)
BX486543   .n 2524 to 3117 612 to 20   AAA Submitted on the opposite strand 593/593
(100 %)
2 diff
(99.7 %id)
CN430439 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .n 2537 to 3118 1 to 582   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 582/582
(100 %)
1 diff
(99.9 %id)
TI_149273701   .n 2542 to 3094 56 to 608     Submitted on the opposite strand 553/1056
(52 %)
1 diff
(100.0 %id)
BM968159 lung, Primary Lung Epithelial Cells .n 2545 to 3094 1 to 550     Submitted on the opposite strand 550/557
(98 %)
1 diff
(99.9 %id)
DB321711   .n 2569 to 3118 550 to 1       550/550
(100 %)
3 diff
(99.5 %id)
BE836253 prostate_normal .n 2586 to 2907 322 to 2       321/330
(97 %)
0 diff
(100 %id)
BE770107 prostate_tumor .n 2591 to 2954 362 to 2       361/362
(99 %)
0 diff
(100 %id)
CA314134 Human Lung Epithelial cells, lung .n 2604 to 3118 533 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 515/524
(98 %)
1 diff
(99.9 %id)
CF995376 Pooled Chondrosarcoma Tumor cells .n 2615 to 3115 88 to 598       511/1152
(44 %)
26 diff
(97.8 %id)
C00279   .n 2617 to 2947 1 to 331       331/336
(98 %)
3 diff
(99.2 %id)
AA071159   .n 2622 to 3118 8 to 502       495/503
(98 %)
5 diff
(99.1 %id)
TI_57230562   .n 2622 to 3117 34 to 530   AAA   497/717
(69 %)
7 diff
(99.1 %id)
BI868971 adenocarcinoma, cell line, Liver .n 2623 to 3117 1 to 496   AAA   496/716
(69 %)
7 diff
(99.1 %id)
CA418657 Chondrosarcoma Grade II, Left Pelvis .n 2631 to 3118 506 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 488/497
(98 %)
0 diff
(100 %id)
DB320323.
matches multiple genes
Kidney .n 2637 to 3118 478 to 5     also hits gene NFE2L1 474/482
(98 %)
0 diff
(100 %id)
BU631339 cell lines, Chondrosarcoma .n 2648 to 3118 489 to 19   AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 471/471
(100 %)
0 diff
(100 %id)
BG115709 duodenal adenocarcinoma, cell line, small intestine .n 2660 to 3089 48 to 477       430/477
(90 %)
0 diff
(100 %id)
AW131434 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .n 2664 to 3118 456 to 1       456/456
(100 %)
2 diff
(99.6 %id)
DB530532 hippocampus .n 2692 to 3116 1 to 426     Submitted on the opposite strand 426/428
(99 %)
9 diff
(97.9 %id)
AW189218 serous papillary carcinoma, high grade, 2pooled tumors, uterus .n 2699 to 3118 420 to 1       420/420
(100 %)
0 diff
(100 %id)
AW079963 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .n 2705 to 3112 429 to 22   AAA   408/414
(98 %)
0 diff
(100 %id)
AI435402 pooled .n 2742 to 3118 383 to 7       377/383
(98 %)
0 diff
(100 %id)
AA911353 carcinoid, lung .n 2761 to 3118 358 to 1       358/358
(100 %)
1 diff
(99.8 %id)
DB545364 hippocampus .n 2769 to 3118 1 to 372     Submitted on the opposite strand 372/372
(100 %)
23 diff
(93.9 %id)
R48186 breast .n 2808 to 3118 318 to 1   fully sequenced,   318/318
(100 %)
8 diff
(97.5 %id)
H42886 breast .n 2869 to 3093 225 to 1   fully sequenced,   225/225
(100 %)
0 diff
(100 %id)
AW602033 breast .n 2906 to 3120 234 to 22       213/234
(91 %)
0 diff
(100 %id)
BQ278774 adenocarcinoma, cell line, breast .o 1 to 838 1 to 841 G161X Q172P V173G D174G V175C ...     839/1082
(77 %)
9 diff
(99.2 %id)
BU856922 adenocarcinoma, cell line, breast .o 1 to 787 1 to 798 L182P K183Q E184G L185A A186G ...     796/942
(84 %)
8 diff
(99.2 %id)
BU857184 adenocarcinoma, cell line, breast .o 1 to 833 1 to 834 N99K S100G tiling clone,   834/846
(98 %)
4 diff
(99.6 %id)
BU944747 adenocarcinoma, cell line, breast .o 1 to 835 1 to 836 G203X G204S tiling clone,   836/853
(98 %)
5 diff
(99.5 %id)
BG334162 melanotic melanoma, skin .o 17 to 738 1 to 715       630/955
(65 %)
19 diff
(98.1 %id)
AI887747 serous papillary carcinoma, high grade, 2pooled tumors, uterus .o 264 to 835 596 to 23   tiling clone, AAA Possibly primed on the genome, locally A rich (13/14 A in genome downstream of last aligned base) 574/574
(100 %)
18 diff
(96.9 %id)
AW876876 pnet .o 311 to 769 459 to 1       459/459
(100 %)
2 diff
(99.6 %id)
BG333187 large cell carcinoma, lung .p 1 to 628 1 to 629       629/629
(100 %)
7 diff
(98.9 %id)
BG333364 large cell carcinoma, lung .p 1 to 799 1 to 802   tiling clone,   801/803
(99 %)
33 diff
(95.9 %id)
BM453702 melanotic melanoma, skin .p 5 to 844 1 to 856   tiling clone,   856/890
(96 %)
16 diff
(98.3 %id)
BM009920 amelanotic melanoma, cell line, skin .p 39 to 866 1 to 827       827/829
(99 %)
11 diff
(98.7 %id)
TI_59384704   .p 40 to 866 58 to 883       826/828
(99 %)
10 diff
(98.8 %id)
AA486421   .p 254 to 740 1 to 473     Submitted on the opposite strand 476/474
(100 %)
16 diff
(96.7 %id)
DB464332 hippocampus .p 424 to 851 1 to 429       429/429
(100 %)
37 diff
(91.4 %id)
AL551495 placenta, Placenta Cot 25-normalized .p 450 to 1469 20 to 1038 G161X K162E N163E F164L A165R ... tiling clone, fully sequenced, to resequence,   1019/1038
(98 %)
18 diff
(98.3 %id)
BG339547 leiomyosarcoma cell line, uterus .p 455 to 978 1 to 517       517/653
(79 %)
21 diff
(96.8 %id)
BG120859 adenocarcinoma, cell line, Liver .p 477 to 1128 1 to 640       640/931
(68 %)
16 diff
(98.3 %id)
BM913893 astrocytoma grade IV, cell line, brain .p 478 to 975 1 to 498       498/1202
(41 %)
20 diff
(98.4 %id)
CN314899 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .p 482 to 893 1 to 412       412/412
(100 %)
0 diff
(100 %id)
CN314903 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .p 482 to 1144 1 to 663   tiling clone,   663/663
(100 %)
2 diff
(99.7 %id)
H47146 liver and spleen .p 497 to 874 1 to 382       382/383
(99 %)
14 diff
(96.4 %id)
H87311 eye, retina .p 499 to 769 4 to 276       273/283
(96 %)
8 diff
(97.2 %id)
DA464852   .p 1249 to 1809 2 to 562   tiling clone, capped   561/562
(99 %)
1 diff
(99.9 %id)
BI039392 nervous_tumor .p 1273 to 1863 1 to 590   tiling clone,   590/590
(100 %)
2 diff
(99.7 %id)
BF057934 brain, oligodendroglioma .p 1349 to 1721 376 to 4     Submitted on the opposite strand 373/376
(99 %)
0 diff
(100 %id)
AL575170 placenta, Placenta Cot 25-normalized .p 1460 to 2537 1066 to 4   tiling clone, fully sequenced, to resequence,   1012/1015
(99 %)
49 diff
(95.2 %id)
BG461234   .q 1 to 649 1 to 649 exact tiling clone,   649/654
(99 %)
2 diff
(99.7 %id)
DA343177 substantia nigra .r 1 to 585 2 to 586 exact tiling clone, capped   585/585
(100 %)
1 diff
(99.9 %id)
BJ990174 hepatoblastoma .r 220 to 797 1 to 578 exact tiling clone,   578/578
(100 %)
0 diff
(100 %id)
BJ990175 hepatoblastoma .r 2243 to 2781 540 to 1   tiling clone,   540/540
(100 %)
1 diff
(99.9 %id)
BQ308072 breast .s-u 1 to 534 19 to 550 W19C W92G L93F Q94R tiling clone,   532/552
(96 %)
6 diff
(99.0 %id)
W92613 heart .t 1 to 157 1 to 158   tiling clone, fully sequenced,   158/158
(100 %)
0 diff
(100 %id)
W94540 heart .t 96 to 508 412 to 1 C33X S78E G79C F80S R81A ... tiling clone, fully sequenced,   412/412
(100 %)
5 diff
(98.8 %id)
AW794421 uterus .u-u 1 to 332 1 to 332 D4Y tiling clone,   332/341
(97 %)
4 diff
(98.9 %id)
AW991668 breast_normal .u-u 1 to 332 1 to 332 D4Y     332/341
(97 %)
4 diff
(98.9 %id)
BQ376657 uterus .u-u 1 to 328 1 to 328 D4Y tiling clone,   328/328
(100 %)
3 diff
(99.1 %id)
S94539   .va-u 1 to 325 1 to 322   tiling clone,   322/322
(100 %)
4 diff
(98.8 %id)
AV707558 adrenal gland Gene ERCC1, variant not shown         Suspected internal deletion, this clone was ignored    
BG897372 cartilage Gene ERCC1, variant not shown         This clone was ignored    
AA335265 epididymis Gene ERCC1, variant not shown         This clone was ignored    
AA968552 Kidney, kidney tumor Gene ERCC1, variant not shown         Suspected internal deletion, this clone was ignored    
AI623793 adenocarcinoma, Pancreas Gene ERCC1, variant not shown         This clone was ignored    
BQ648919 hepatocellular carcinoma, cell line, Liver Gene ERCC1, variant not shown       AAA Suspected internal deletion, this clone was ignored    
BU954258 mixed (pool of 40 RNAs) Gene ERCC1, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i, .j, .k, .l, .m, .n, .o, .p, .q, .r, .s-u, .t, .u-u, .va-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI